Found: 55
Select item for more details and to access through your institution.
Phase 2 multicentre study of single‐agent ofatumumab in previously untreated follicular lymphoma: CALGB 50901 (Alliance).
- Published in:
- Angewandte Chemie, 2019, v. 131, n. 15, p. 53, doi. 10.1111/bjh.15768
- By:
- Publication type:
- Article
Neuro-oncology at the American Society for Clinical Oncology 2022 Annual Meeting.
- Published in:
- Neuro-Oncology Practice, 2022, v. 9, n. 6, p. 552, doi. 10.1093/nop/npac071
- By:
- Publication type:
- Article
Fimepinostat (CUDC‐907) in patients with relapsed/refractory diffuse large B cell and high‐grade B‐cell lymphoma: report of a phase 2 trial and exploratory biomarker analyses.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 2, p. 201, doi. 10.1111/bjh.17730
- By:
- Publication type:
- Article
Phase 2 multicentre study of single‐agent ofatumumab in previously untreated follicular lymphoma: CALGB 50901 (Alliance).
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 1, p. 53, doi. 10.1111/bjh.15768
- By:
- Publication type:
- Article
University of Chicago phase II consortium trial of selumetinib (MEKi) demonstrates low tolerability and efficacy in relapsed DLBCL.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 2, p. 264, doi. 10.1111/bjh.14544
- By:
- Publication type:
- Article
Outcomes of adults and children with primary mediastinal B-cell lymphoma treated with dose-adjusted EPOCH-R.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 5, p. 739, doi. 10.1111/bjh.14951
- By:
- Publication type:
- Article
RB but not R- HCVAD is a feasible induction regimen prior to auto- HCT in frontline MCL: results of SWOG Study S1106.
- Published in:
- British Journal of Haematology, 2017, v. 176, n. 5, p. 759, doi. 10.1111/bjh.14480
- By:
- Publication type:
- Article
Outcomes of MYC-associated lymphomas after R- CHOP with and without consolidative autologous stem cell transplant: subset analysis of randomized trial intergroup SWOG S9704.
- Published in:
- British Journal of Haematology, 2016, v. 174, n. 5, p. 686, doi. 10.1111/bjh.14100
- By:
- Publication type:
- Article
A phase II study of cyclophosphamide, etoposide, vincristine and prednisone ( CEOP) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma ( PTCL): final results from the T- cell consortium trial.
- Published in:
- British Journal of Haematology, 2016, v. 172, n. 4, p. 535, doi. 10.1111/bjh.13855
- By:
- Publication type:
- Article
Phase II trial of R- CHOP plus bortezomib induction therapy followed by bortezomib maintenance for newly diagnosed mantle cell lymphoma: SWOG S0601.
- Published in:
- British Journal of Haematology, 2016, v. 172, n. 2, p. 208, doi. 10.1111/bjh.13818
- By:
- Publication type:
- Article
Mechanisms of ibrutinib resistance in chronic lymphocytic leukaemia and non-Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2015, v. 170, n. 4, p. 445, doi. 10.1111/bjh.13427
- By:
- Publication type:
- Article
Pre-diagnosis cigarette smoking and overall survival in non- Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2013, v. 163, n. 3, p. 352, doi. 10.1111/bjh.12512
- By:
- Publication type:
- Article
A phase I/II trial of bortezomib combined concurrently with gemcitabine for relapsed or refractory DLBCL and peripheral T-cell lymphomas.
- Published in:
- British Journal of Haematology, 2013, v. 163, n. 1, p. 55, doi. 10.1111/bjh.12488
- By:
- Publication type:
- Article
Follicular Lymphoma: a Focus on Current and Emerging Therapies.
- Published in:
- Oncology (08909091), 2022, v. 36, n. 2, p. 97
- By:
- Publication type:
- Article
ACR Appropriateness Criteria® Recurrent Hodgkin Lymphoma.
- Published in:
- Oncology (08909091), 2016, v. 30, n. 12, p. 1099
- By:
- Publication type:
- Article
From Minimal Residual Disease to Maintenance Therapy: Optimizing Tools for Treatment of Mantle Cell Lymphoma.
- Published in:
- Oncology (08909091), 2016, v. 30, n. 4, p. 361
- By:
- Publication type:
- Article
Clinical Malignant Hematology.
- Published in:
- 2007
- By:
- Publication type:
- Book Review
Alterations of 5-hydroxymethylation in circulating cell-free DNA reflect molecular distinctions of subtypes of non-Hodgkin lymphoma.
- Published in:
- NPJ Genomic Medicine, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41525-021-00179-8
- By:
- Publication type:
- Article
Evolving Strategies for the Management of Transformed Lymphoma.
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, n. 10, p. 624
- By:
- Publication type:
- Article
DA-R-EPOCH vs R-CHOP in DLBCL: How Do We Choose?
- Published in:
- Clinical Advances in Hematology & Oncology, 2021, v. 19, n. 11, p. e698
- By:
- Publication type:
- Article
Dietary patterns and the risk of non-Hodgkin lymphoma.
- Published in:
- Public Health Nutrition, 2014, v. 17, n. 7, p. 1531, doi. 10.1017/S1368980013001249
- By:
- Publication type:
- Article
Rapid Neurologic Decline in a Patient With Peripheral T-Cell Lymphoma: A Case of Leptomeningeal Lymphomatosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 1, p. 70, doi. 10.1016/j.clml.2012.07.002
- By:
- Publication type:
- Article
Nonmyeloablative transplantation for lymphoma.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Phytanic acid and the risk of non-Hodgkin lymphoma.
- Published in:
- Carcinogenesis, 2013, v. 34, n. 1, p. 170, doi. 10.1093/carcin/bgs315
- By:
- Publication type:
- Article
Optimization of Metabolic Tumor Volume as a Prognostic Marker in CAR T-Cell Therapy for Aggressive Large B-cell NHL.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 2, p. 83, doi. 10.1016/j.clml.2023.09.005
- By:
- Publication type:
- Article
Characteristics and Outcome of Extranodal NK/T-cell Lymphoma in North America: A Retrospective Multi-Institutional Experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 5, p. e300, doi. 10.1016/j.clml.2021.10.018
- By:
- Publication type:
- Article
Characteristics and Outcome of Extranodal NK/T-Cell Lymphoma in North America: A Retrospective Multi-Institutional Experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 4, p. e250, doi. 10.1016/j.clml.2021.10.004
- By:
- Publication type:
- Article
Phase II Study of the PD-1 Inhibitor Pembrolizumab for the Treatment of Relapsed or Refractory Mature T-cell Lymphoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Should We Use Cell of Origin and Dual-protein Expression in Treating DLBCL?
- Published in:
- 2018
- By:
- Publication type:
- journal article
Analysis of Peripheral T-cell Lymphoma Diagnostic Workup in the United States.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Selective enhancement of ifosfamide-induced toxicity in Chinese hamster ovary cells.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Evolution of therapy for limited stage diffuse large B-cell lymphoma.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 2, p. 1, doi. 10.1038/s41408-021-00596-z
- By:
- Publication type:
- Article
Post‐transplant lymphoproliferative disorder subtypes correlate with different recurring chromosomal abnormalities.
- Published in:
- Genes, Chromosomes & Cancer, 2006, v. 45, n. 3, p. 313, doi. 10.1002/gcc.20287
- By:
- Publication type:
- Article
Treatment of aggressive B-cell lymphomas.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A phase I/II trial of vorinostat (SAHA) in combination with rituximab‐CHOP in patients with newly diagnosed advanced stage diffuse large B‐cell lymphoma (DLBCL): SWOG S0806.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 4, p. 486, doi. 10.1002/ajh.25010
- By:
- Publication type:
- Article
Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: Characteristics, outcomes, and prognostication among a large multicenter cohort.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 9, p. 778, doi. 10.1002/ajh.24082
- By:
- Publication type:
- Article
The impact of race, age, and sex in follicular lymphoma: A comprehensive SEER analysis across consecutive treatment eras.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 6, p. 633, doi. 10.1002/ajh.23708
- By:
- Publication type:
- Article
Rituximab-containing reduced-intensity conditioning improves progression-free survival following allogeneic transplantation in B cell non-Hodgkin lymphoma.
- Published in:
- Journal of Hematology & Oncology, 2017, v. 10, p. 1, doi. 10.1186/s13045-017-0487-y
- By:
- Publication type:
- Article
Phase 1 study of lenalidomide plus dose‐adjusted EPOCH‐R in patients with aggressive B‐cell lymphomas with deregulated MYC and BCL2.
- Published in:
- Cancer (0008543X), 2019, v. 125, n. 11, p. 1830, doi. 10.1002/cncr.31877
- By:
- Publication type:
- Article
The role of autologous stem cell transplantation in patients with nodal peripheral T-cell lymphomas in first complete remission: Report from COMPLETE, a prospective, multicenter cohort study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Phase 1 study of lenalidomide plus dose-adjusted EPOCH-R in patients with aggressive B-cell lymphomas with deregulated MYC and BCL2.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Double hit and double expressors in lymphoma: Definition and treatment.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Allogeneic hematopoietic stem cell transplantation for relapsed follicular lymphoma: A combined analysis on behalf of the Lymphoma Working Party of the EBMT and the Lymphoma Committee of the CIBMTR.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols: An adult intergroup (E2496) and Children's Oncology Group (COG AHOD0031) comparative analysis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A prospective cohort study of patients with peripheral T-cell lymphoma in the United States.
- Published in:
- 2017
- By:
- Publication type:
- journal article
MYC-associated and double-hit lymphomas: A review of pathobiology, prognosis, and therapeutic approaches.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 24, p. 3884, doi. 10.1002/cncr.28899
- By:
- Publication type:
- Article
A phase 2 study of epothilone B analog BMS-247550 (NSC 710428) in patients with relapsed aggressive non-Hodgkin lymphomas.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 9, p. 1683, doi. 10.1002/cncr.27917
- By:
- Publication type:
- Article
Prognosis in diffuse large B-cell lymphoma: the picture continues to come into focus.
- Published in:
- 2013
- By:
- Publication type:
- Editorial
Prognosis in diffuse large B-cell lymphoma.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 6, p. 1129, doi. 10.1002/cncr.27860
- By:
- Publication type:
- Article